FMR LLC
CIK 315066 · last filed 2026-05-05
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
Loading insider history…
Disclosed Exposure
$482.28M
Companies
37
Total Filings
162
Lifetime Open-Market Net
-$158.52M
Holdings By Company
Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| AVLN | 10%+ Owner | 727,585 | — | — | $0 | 1 | 2026-05-05 |
| GPCR | 10%+ Owner | 241,275 | $42.93 | $10.36M | $0 | 12 | 2026-04-16 |
| Metsera, Inc. (MTSR) Delisted | 10%+ Owner | 3,010 | $70.50 | $212.2K | -$21.5K | 6 | 2025-11-12 |
| BEAM | 10%+ Owner | 841,231 | $29.03 | $24.42M | -$30.79M | 14 | 2025-10-29 |
| SANA | 10%+ Owner | 4,707,423 | $2.68 | $12.62M | -$1.89M | 1 | 2025-01-10 |
| BCAX | 10,818 | $21.69 | $234.6K | $0 | 1 | 2024-09-18 | |
| Turnstone Biologics Corp. (TSBX) Delisted | 10%+ Owner | 296,396 | $0.35 | $105.2K | $0 | 2 | 2024-01-11 |
| NMRA | 1,911,729 | $1.78 | $3.40M | $0 | 1 | 2023-09-21 | |
| PRME | 98,967 | $2.77 | $274.6K | $0 | 1 | 2022-10-26 | |
| Verve Therapeutics, Inc. (VERV) Delisted | 10%+ Owner | 570,729 | $11.13 | $6.35M | -$11.30M | 9 | 2022-07-28 |
| TOST | — | $24.82 | — | $0 | 1 | 2021-11-12 | |
| XLO | 4,465 | $8.31 | $37.1K | $0 | 1 | 2021-10-28 | |
| RLYB | 1,694,388 | $15.92 | $26.97M | $0 | 1 | 2021-08-04 | |
| CRBU | 17,572 | $1.59 | $28.0K | $0 | 1 | 2021-07-29 | |
| FLYW | 7,249,056 | $14.71 | $106.63M | $0 | 1 | 2021-06-02 | |
| Orchard Therapeutics plc (ORTX) Delisted | 10%+ Owner | 4,099,540 | $16.70 | $68.46M | -$14.43M | 3 | 2021-02-23 |
| DTIL | 3,738,248 | $6.10 | $22.80M | $800.0K | 1 | 2019-04-03 | |
| ViewRay, Inc. (VRAY) Delisted | 10%+ Owner | 1,620 | $0.03 | $40 | -$26.21M | 18 | 2018-08-10 |
| Surface Oncology, Inc. (SURF) Delisted | 10%+ Owner | 1,888,986 | $1.07 | $2.02M | $0 | 1 | 2018-04-25 |
| Cogent Biosciences, Inc. (UMRX) Delisted | 1,890,701 | — | — | $1.13M | 1 | 2018-04-05 | |
| VYNE Therapeutics Inc. (MNLO) Delisted | 813,478 | — | — | $0 | 1 | 2018-01-31 | |
| DNLI | 31,969 | $21.66 | $692.4K | $0 | 1 | 2017-12-14 | |
| Mersana Therapeutics, Inc. (MRSN) Delisted | 2,597 | $29.08 | $75.5K | $0 | 1 | 2017-07-06 | |
| KINETA, INC./DE (PTI) Delisted | 10%+ Owner | 243,508 | — | — | -$451.8K | 8 | 2017-03-15 |
| ACRS | 10%+ Owner | 1,931,727 | $4.32 | $8.35M | $3.61M | 6 | 2016-12-21 |
| EXA CORP (EXA) Delisted | 10%+ Owner | 0 | — | — | -$19.35M | 2 | 2016-10-11 |
| CHRS | 10%+ Owner | 361,594 | $1.40 | $506.2K | -$4.37M | 2 | 2016-08-10 |
| RGNX | 10%+ Owner | 619,376 | $6.66 | $4.13M | -$2.38M | 15 | 2016-05-18 |
| Dimension Therapeutics, Inc. (DMTX) Delisted | 10%+ Owner | 4,893,322 | — | — | $0 | 2 | 2016-05-03 |
| Blueprint Medicines Corp (BPMC) Delisted | 10%+ Owner | 496,813 | $129.46 | $64.32M | -$16.84M | 8 | 2015-11-30 |
| TETRAPHASE PHARMACEUTICALS INC (TTPH) Delisted | 10%+ Owner | 2,141,645 | — | — | $4.50M | 3 | 2015-03-09 |
| RARE | 10%+ Owner | 1,457,994 | $24.35 | $35.50M | $3.67M | 2 | 2014-08-05 |
| GNRC | 10%+ Owner | 763,071 | $262.36 | $200.20M | $1.28M | 1 | 2014-07-03 |
| XOOM Corp (XOOM) Delisted | 10%+ Owner | 2,619,036 | — | — | -$13.6K | 4 | 2013-08-30 |
| INSM | 10%+ Owner | 2,575 | $97.85 | $252.0K | -$17.47M | 9 | 2013-07-23 |
| IRWD | 10%+ Owner | 837,736 | $3.65 | $3.06M | -$17.62M | 12 | 2013-04-02 |
| ASIA | 10%+ Owner | 498,711 | $43.74 | $21.81M | -$10.38M | 3 | 2010-09-22 |
Recent Filings · Page 4 of 17
162 filingsForm 4 transactions across all companies, newest first.
| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2023-07-27 | Turnstone Biologics Corp. (TSBX) Delisted | Conv (C) | +1,133,987 | $0 | EDGAR |
| 2023-06-29 | — | Buy (P) | +346,722 | $8.75M | |
| 2023-02-09 | GPCR | Conv (C) | +5,816,554 | $0 | EDGAR |
| 2022-10-26 | PRME | Conv (C) | +8,462,946 | $0 | EDGAR |
| 2022-09-08 | BEAM | Mixed | −25,620 | -$29.9K | EDGAR |
| 2022-08-08 | BEAM | Mixed | −474,686 | -$1.23M | EDGAR |
| 2022-07-28 | Verve Therapeutics, Inc. (VERV) Delisted | — | — | $0 | EDGAR |
| 2022-07-14 | Verve Therapeutics, Inc. (VERV) Delisted | Sell (S) | −163,000 | -$3.39M | EDGAR |
| 2022-07-06 | Verve Therapeutics, Inc. (VERV) Delisted | Sell (S) | −38,775 | -$607.2K | EDGAR |
| 2022-07-01 | Verve Therapeutics, Inc. (VERV) Delisted | Sell (S) | −53,219 | -$822.5K | EDGAR |
Codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.